Cell Responses to Electrical Pulse Stimulation for Anticancer Drug Release

Area of Science:

• Biomaterials Science
• Nanotechnology
• Cancer Therapeutics

Background:

• Electrical stimulation offers a promising method for on-demand drug release.
• Progress in electrically controlled drug release is hindered by a lack of understanding of cell responses to electrical stimuli.
• Existing research often overlooks cellular behavior when developing smart materials for drug delivery.

Purpose of the Study:

• To evaluate the behavior of prostate (PC-3) and breast (MCF7) cancer cells exposed to electroactive drug delivery platforms.
• To differentiate cellular damage caused by electrical stimulation from the effects of curcumin and its carriers.
• To assess the efficacy of electroactive platforms for controlled drug delivery under specific conditions.

Main Methods:

• Utilized conducting polymer nanoparticles and electrospun polyester microfibers loaded with curcumin.
• Investigated cellular viability, metabolism, spreading, and shape in response to electrical stimulation.
• Examined the electro-mechanical actuation mechanism of nanoparticles within microfibers to alter matrix porosity.

Main Results:

• Successfully differentiated cellular damage induced by electrical stimulation from the inherent anticancer effects of curcumin.
• Demonstrated that electroactive platforms can modulate drug release and impact cancer cell behavior.
• Observed distinct cellular responses (viability, metabolism, morphology) to varying electrical conditions and drug carrier presence.

Conclusions:

• Electroactive platforms show potential for controlled drug delivery, particularly for hydrophobic anticancer drugs like curcumin.
• Understanding cellular responses to electrical stimulation is crucial for optimizing these drug delivery systems.
• These platforms can be effective for targeted drug delivery when dosage and conditions are carefully managed.